Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 37, 2002 - Issue 10
Submit an article Journal homepage
40
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Benefit of Population-based Screening for Phenotypic Hemochromatosis in Young Men

A. Åsberg
,
S. Tretli
,
K. Hveem
&
K. S. Bjerve
Pages 1212-1219 | Published online: 08 Jul 2009

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Arne Åsberg, Kristian Hveem, Kjell Kannelønning & Wenche Øiestad Irgens. (2007) Penetrance of the C28Y/C282Y genotype of the HFE gene. Scandinavian Journal of Gastroenterology 42:9, pages 1073-1077.
Read now
S. Distante. (2006) Genetic predisposition to iron overload: Prevalence and phenotypic expression of hemochromatosis‐associated HFE‐C282Y gene mutation. Scandinavian Journal of Clinical and Laboratory Investigation 66:2, pages 83-100.
Read now

Articles from other publishers (14)

Malvina Hoxha, Visar Malaj & Bruno Zappacosta. (2024) Health Economic Evaluations of Hemochromatosis Screening and Treatment: A Systematic Review. PharmacoEconomics - Open 8:2, pages 147-170.
Crossref
Jody C. Olson & Patrick S. Kamath. 2018. Hepatic Critical Care. Hepatic Critical Care 75 82 .
Barbara de Graaff, Amanda Neil, Lei Si, Kwang Chien Yee, Kristy Sanderson, Lyle Gurrin & Andrew J. Palmer. (2016) Cost-Effectiveness of Different Population Screening Strategies for Hereditary Haemochromatosis in Australia. Applied Health Economics and Health Policy 15:4, pages 521-534.
Crossref
Barbara de Graaff, Lei Si, Amanda L. Neil, Kwang Chien Yee, Kristy Sanderson, Lyle C. Gurrin & Andrew J. Palmer. (2016) Population Screening for Hereditary Haemochromatosis in Australia: Construction and Validation of a State-Transition Cost-Effectiveness Model. PharmacoEconomics - Open 1:1, pages 37-51.
Crossref
Barbara de Graaff, Amanda Neil, Kristy Sanderson, Kwang Chien Yee & Andrew J. Palmer. (2017) Costs associated with hereditary haemochromatosis in Australia: a cost-of-illness study. Australian Health Review 41:3, pages 254.
Crossref
Barbara de Graaff, Amanda Neil, Kristy Sanderson, Kwang Chien Yee & Andrew J. Palmer. (2016) Quality of life utility values for hereditary haemochromatosis in Australia. Health and Quality of Life Outcomes 14:1.
Crossref
Barbara de Graaff, Amanda Neil, Kristy Sanderson, Lei Si, Kwang Chien Yee & Andrew J. Palmer. (2015) A Systematic Review and Narrative Synthesis of Health Economic Studies Conducted for Hereditary Haemochromatosis. Applied Health Economics and Health Policy 13:5, pages 469-483.
Crossref
W.H. Rogowski, S.D. Grosse, E. Meyer, J. John & S. Palmer. (2012) Die Nutzung von Informationswertanalysen in Entscheidungen über angewandte ForschungUsing value of information analysis in decision making about applied research. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 55:5, pages 700-709.
Crossref
James C. Barton, Corwin Q. Edwards, Pradyumna D. Phatak, Robert S. Britton & Bruce R. BaconJames C. Barton, Corwin Q. Edwards, Pradyumna D. Phatak, Robert S. Britton & Bruce R. Bacon. 2011. Handbook of Iron Overload Disorders. Handbook of Iron Overload Disorders 342 346 .
Wolf H. Rogowski. (2008) The Cost-Effectiveness of Screening for Hereditary Hemochromatosis in Germany: A Remodeling Study. Medical Decision Making 29:2, pages 224-238.
Crossref
Dorine W Swinkels, Mirian CH Janssen, Jürgen Bergmans & Joannes JM Marx. (2006) Hereditary Hemochromatosis: Genetic Complexity and New Diagnostic Approaches. Clinical Chemistry 52:6, pages 950-968.
Crossref
Ernest Beutler. (2006) Hemochromatosis: Genetics and Pathophysiology. Annual Review of Medicine 57:1, pages 331-347.
Crossref
Christine Patch, Paul Roderick & William Rosenberg. (2005) Factors affecting the uptake of screening: A randomised controlled non-inferiority trial comparing a genotypic and a phenotypic strategy for screening for haemochromatosis. Journal of Hepatology 43:1, pages 149-155.
Crossref
Ernest Beutler. (2003) Rebuttal to Ajioka and Kushner. Blood 101:9, pages 3354-3357.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.